FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Jazz Tremor Drug Misses Primary Endpoint

Jazz Pharmaceuticals says data from its Phase 2b clinical trial evaluating the efficacy and safety of suvecaltamide in adult patients with essential t...

latest-news-card-1
Human Drugs

J&J Seeks Tremfya Crohns Indication

Johnson & Johnson asks FDA to approve a new indication for its Tremfya to treat some adults with Crohns disease.

latest-news-card-1
Medical Devices

De Novo for Onkos Implant Antibacterial Coating

FDA grants Onkos Surgical a de novo authorization for its novel antibacterial coating for use with implants.

latest-news-card-1

2023 Trial Diversity Workshop Report

FDA publishes its report on an 11/2023 workshop on increasing clinical trial diversity.

latest-news-card-1
Federal Register

Guide on ANDA Facility Inspection Readiness

Federal Register notice: FDA makes available a final guidance entitled Facility Readiness: Goal Date Decisions Under GDUFA.

latest-news-card-1
Federal Register

Animal Drug User Fee Educational Conference

Federal Register notice: FDA announces a 7/17 educational conference (public meeting) entitled First Annual Animal Drug User Fee Educational Conferenc...

latest-news-card-1
Medical Devices

Former Device Company CEO Gets 6 Years in Prison

A New York federal judge orders Stimwave founder and former CEO Laura Perryman to serve six years in jail for medical device healthcare fraud.

latest-news-card-1
Medical Devices

FDA Asks Input on Non-Device Software Functions, Impacts

FDA asks for input on certain non-device software functions and impacts on patient safety.

latest-news-card-1
Human Drugs

Protein Data Bank Aided 100% of Targeted Cancer Drugs: Study

Academic researchers say all 34 low molecular weight, protein-targeted, antineoplastic agents approved by FDA between 2019 and 2023 were facilitated i...

latest-news-card-1
Human Drugs

Truqap Misses Endpoints in Breast Cancer Trial

AstraZeneca says its CAPItello-290 Phase 3 trial of Truqap (capivasertib) in combination with paclitaxel in patients with locally advanced or metastat...